SMRI - ETF AI Analysis
Top Page
Bushido Capital US Equity ETF (SMRI)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, indicating solid recent momentum.
Energy Leaders Driving Returns
Several top energy holdings, such as major refiners, have shown strong performance, helping lift the fund’s overall results.
Broad Sector Mix Within the U.S.
Exposure to multiple sectors like technology, energy, health care, and consumer stocks helps spread risk across different parts of the U.S. economy.
Negative Factors
High U.S.-Only Concentration
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market weakens.
Several Weak Top Holdings
A number of the largest positions, especially in technology and software, have shown weak performance this year, which could drag on future returns if the trend continues.
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, meaning more of the returns are used to cover fees instead of going to investors.
SMRI vs. SPDR S&P 500 ETF (SPY)
AUM710.20M
RegionNorth America
Expense Ratio0.71%
Beta0.83
IssuerBushido
Inception DateSep 14, 2023
Dividend Yield0.78%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume20,046
30 Day Avg. Volume11,978
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
53.01Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering51
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SMRI Summary
The Bushido Capital US Equity ETF (SMRI) is an actively managed fund that invests in a wide mix of U.S. companies, with a focus on finding stocks that appear undervalued but have room to grow. It doesn’t track a set index, but follows a “total market” value theme, spreading money across technology, energy, health care, and more. Well-known holdings include Adobe and Accenture. Someone might invest in SMRI to seek long-term growth while staying diversified across many sectors. A key risk is that its stock prices can rise and fall with the overall U.S. market, and its value focus may lag when growth stocks are in favor.
How much will it cost me?The Bushido Capital US Equity ETF (Ticker: SMRI) has an expense ratio of 0.72%, meaning you’ll pay $7.20 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.
What would affect this ETF?The Bushido Capital US Equity ETF (SMRI) could benefit from growth in the technology and healthcare sectors, which make up a significant portion of its holdings, especially if innovation and demand in these areas continue to rise. However, potential risks include economic downturns or rising interest rates, which could negatively impact value stocks and sectors like energy and consumer cyclical. Regulatory changes or geopolitical tensions affecting U.S. markets may also influence the ETF's performance.
SMRI Top 10 Holdings
SMRI is leaning heavily on U.S. energy and health care names, with refiners like Marathon Petroleum, Valero, and Phillips 66 doing much of the heavy lifting as they continue to rise and fuel the fund’s recent momentum. On the health care side, Jazz Pharmaceuticals and Incyte are steady contributors, adding a bit of defensive ballast. Not everything is firing, though: software names like Veeva Systems and Workday are more mixed, with Workday in particular losing steam and acting as a bit of a drag. Overall, it’s a U.S.-only portfolio with a clear tilt toward energy-powered value plays.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Workday | 2.85% | $20.26M | $48.74B | -9.61% | 73 Outperform | |
| Veeva Systems | 2.63% | $18.67M | $40.70B | -14.77% | 66 Neutral | |
| Tenet Healthcare | 2.48% | $17.60M | $21.95B | 56.42% | 74 Outperform | |
| Marathon Petroleum | 2.42% | $17.18M | $100.60B | 111.10% | 66 Neutral | |
| Accenture | 2.40% | $17.05M | $110.98B | -28.52% | 79 Outperform | |
| Phillips 66 | 2.36% | $16.73M | $95.77B | 86.91% | 73 Outperform | |
| Valero Energy | 2.35% | $16.72M | $98.33B | 139.98% | 69 Neutral | |
| Intuit | 2.34% | $16.58M | $98.98B | -44.62% | 73 Outperform | |
| Leidos Holdings | 2.32% | $16.44M | $17.74B | -22.20% | 77 Outperform | |
| Adobe | 2.29% | $16.28M | $108.21B | -23.97% | 80 Outperform |
SMRI Technical Analysis
Positive
―
Price Trends
43.54
Positive
41.07
Positive
38.47
Positive
Market Momentum
1.46
Negative
81.45
Negative
90.56
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMRI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 46.08, equal to the 50-day MA of 43.54, and equal to the 200-day MA of 38.47, indicating a bullish trend. The MACD of 1.46 indicates Negative momentum. The RSI at 81.45 is Negative, neither overbought nor oversold. The STOCH value of 90.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMRI.
SMRI Peer Comparison
Comparison Results
Performance Comparison
SMRI
Bushido Capital US Equity ETF
48.71
15.27
45.66%
VFMF
Vanguard U.S. Multifactor ETF
―
―
―
AVTM
Avantis Total Equity Markets ETF
―
―
―
BGDV
Bahl & Gaynor Dividend ETF
―
―
―
ULTY
YieldMax Ultra Option Income Strategy ETF
―
―
―
XCHG
AB US Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents